MedPath

青岛百洋制药有限公司

Ownership
-
Established
1990-02-07
Employees
-
Market Cap
-
Website
http://www.bahealpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

NMPA:99

Drug Approvals

Lanthanum Carbonate Chewable Tablets

Product Name
碳酸镧咀嚼片
Approval Number
国药准字H20244877
Approval Date
Sep 10, 2024
NMPA

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20243136
Approval Date
Feb 6, 2024
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20234146
Approval Date
Sep 12, 2023
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20234147
Approval Date
Sep 12, 2023
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20233534
Approval Date
May 12, 2023
NMPA

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20233437
Approval Date
Apr 11, 2023
NMPA

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20233438
Approval Date
Apr 11, 2023
NMPA

Memantine Hydrochloride Sustained -release Capsules

Product Name
盐酸美金刚缓释胶囊
Approval Number
国药准字H20223151
Approval Date
Mar 22, 2022
NMPA

Memantine Hydrochloride Sustained -release Capsules

Product Name
盐酸美金刚缓释胶囊
Approval Number
国药准字H20223152
Approval Date
Mar 22, 2022
NMPA

Memantine Hydrochloride Sustained -release Capsules

Product Name
盐酸美金刚缓释胶囊
Approval Number
国药准字H20223150
Approval Date
Mar 22, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.